Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: A multicenter, randomized, double-blind, placebo-controlled trial
It has undergone a lot of clinical testing (the STEP trial program included more than 4,500 people) that shows it works and is safe, which supports regulatory submissions in big countries
Here are some of the most effective peptide stacks for those looking to maximize longevity and cellular repair: GHK-Cu + BPC-157 (Tissue Repair & Anti-Aging) BPC-157 is a healing peptide, known for tissue repair, reducing inflammation, and protecting the gut
your healthcare professionals
The rise of GLP-1 receptor agonists for use in type 2 diabetes Of the non-insulin treatments available for treating T2D, GLP-1 RAs offer the greatest reductions in HbA 1c , with more recent long-acting GLP-1 RAs matching, or even exceeding, glycaemic improvement achieved with basal insulin in T2D (Nauck et al, 2021)